FDA issues warning letters to companies selling antibody tests - MassDevice

FDA-logo-newThe FDA announced that it issued warning letters to three companies for marketing adulterated and misbranded COVID-19 antibody tests.

Medakit, Antibodiescheck.com and Yama Group and Dr. Jason Korkus, DDS & Sonrisa Family Dental d/b/a My COVID19 Club all received warnings.

In the warnings, the agency outlined violations including offering test kits for sale in the U.S. directly to consumers for at-真人百家家乐app下载home use without marketing approval, clearance or ization from the FDA. The letters also noted misbranding by claiming that products are “FDA-approved” and labeling that bears the FDA logo, which is not meant for use on private sector materials.

The FDA said in a news release that there are no diagnostic or antibody COVID-19 test kits that are ized to be used completely at 真人百家家乐app下载home, but there are tests for use with at-真人百家家乐app下载home sample collection followed by processing and reporting at a laboratory.

Violators are urged to take immediate steps to correct the transgressions, including ceasing the sale of the products or preventing future sales. Failure to immediately correct the cited violations may result in legal action, including possible seizure and injunction.

“Providing regulatory flexibility during this public health emergency never meant we would allow fraud,” FDA Center for Devices & Radiological Health director Dr. Jeff Shuren said in the news release. “When tests are marketed inappropriately, with inaccurate or misleading claims – such as the ability to perform the test completely at 真人百家家乐app下载home, or that the test is ized, cleared, or approved when it is not – they put the health of Americans at risk. Such conduct will not be tolerated by the FDA, and we will continue to monitor tests marketed in the U.S., taking appropriate action as warranted.”

RSS From Medical Design & Outsourcing

  • Wyss Institute lands $16m to repurpose drugs for COVID-19
    Lindsay Brownell, Wyss Institute The U.S. Defense Advanced Research Projects Agency (DARPA) has awarded Harvard university’s Wyss Institute for Biologically Inspired Engineering $16 million to identify and test FDA-approved drugs that could be repurposed to prevent or treat COVID-19. Using its computational drug discovery pipelines and human Organ Chip technologies, the institute has already found… […]
  • FDA extends switch to virtual meetings, warns it may miss some deadlines
    The FDA said Monday that it will continue holding formal meetings with device sponsors virtually due to the COVID-19 pandemic for now. The agency also said that it may miss some deadlines in completing user-fee work on premarket device approval applications. In a Q&A document, the agency said that until further notice, all requests for… […]
  • XaTek to develop rugged ClotChip for U.S. Navy
    XaTek today announced a deal with the U.S. Navy to develop its ClotChip handheld blood coagulation reader for military deployment. The reader measures a patient’s bleeding risk from one drop of blood from a fingerstick. It will be adapted to withstand excessive impact and vibration of trauma patient support. The adaptions will be validated in… […]
  • DOD launches $100m initiative to return COVID-19-related medtech, pharma manufacturing to the U.S.
    The U.S. Department of Defense announced today that it will dedicate $100 million ized by the CARES Act to boost medtech and pharmaceutical manufacturing in the U.S. Working with DOD, the U.S. International Development Finance Corporation (DFC) launched a request for proposals from companies seeking financing under the Defense Production Act, which prioritizes government orders… […]
  • Hahn says FDA will keep some COVID-19-era changes in place
    The head of the FDA says some changes the agency made during the height of the COVID-19 pandemic will become permanent. Dr. Stephen Hahn told members of the Medical Device Innovation Consortium (MDIC) on June 19 that the agency will rely even more on real-world evidence regarding the performance of approved or cleared devices and… […]
  • DeviceTalks Weekly: Stryker CEO Kevin Lobo says medtech can increase workforce diversity
    This week’s DeviceTalks Weekly podcast episode talks with industry leaders about improving worker diversity and developing new ways to treat COVID-19 patients. Kevin Lobo, chairman and CEO of Stryker, explains how his company — and the industry group AdvaMed — has been working  to increase diversity of its workforce, particularly in senior and sales positions.… […]
  • COVID-19 lessons learned: 2 manufacturers, a healthcare system and a logistics company share their wisdom
    The COVID-19 pandemic put medtech contract manufacturers, OEMs, distributors and healthcare providers in situations for which they were unprepared, particularly with their supply chains. What they learned will undoubtedly help them all going forward, especially if the world faces a second wave or another novel virus. Here are some supply chain lessons learned by Nonin… […]
  • Assisted living survey shows ongoing struggle for supplies during COVID-19 pandemic
    A survey of National Center for Assisted Living members revealed that a number of people are still facing equipment shortages during the COVID-19 pandemic. Assisted living facilities have been hit particularly hard by the virus, with a recent report from the Associated Press citing government data confirming that nursing 真人百家家乐app下载home residents account for nearly 1 in 10… […]
  • Medtronic, Foxconn aim to make 10,000 ventilators
    Medtronic (NYSE:MDT) and Foxconn said today they will boost ventilator production to 10,000 over the next year at Foxconn’s Wisconsin plant. The companies announced in April that Foxconn would begin production of Medtronic’s Puritan Bennett 560 ventilators at the plant in Mount Pleasant, Wis., with a goal of 400 ventilators per week by the end of… […]
  • NeuroOne names director of electrode development
    NeuroOne Medical Technologies said this week that it has appointed Camilo Andres Diaz-Botia as director of electrode development. Diaz-Botia previously led the microfabrication process engineering team at Neuralink, a company that’s developing a high-bandwidth brain-machine interface. Under his direction, the team built and designed novel processes for integration of thin-film neural probes with brain-machine interface… […]
  • GE Healthcare launches chest X-ray AI to better spot COVID-19
    Officials at GE Healthcare (NYSE:GE) think the company’s new Thoracic Care Suite — a collection of eight AI algorithms from Lunit Insight CXR — could help clinicians in the fight against COVID-19. The AI suite, launched today, quickly analyzes chest X-ray findings and flags abnormalities for radiologist review, according to GE. It can spot potential pneumonia… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.